Sengenics Corporation LLC

Alexion is a global biopharmaceutical company based in Burlington, dedicated to developing innovative therapies for individuals affected by rare disorders. The company's mission is to provide life-changing treatments that improve the quality of life for those living with rare diseases around the world. Generated from their website's infomation

Antigenics is a biotechnology company working to develop treatments for cancers, infectious diseases and autoimmune disorders. It employs more than 200 people, and has corporate offices in New York City, and research, development and manufacturing facilities in Lexington, Mass. Founded more than 10 years ago, the company has grown through the acquisition of Aronex Pharmaceuticals, a company with products that treat cancer using novel drug formulations designed to reduce toxicity and increase efficacy, and Aquila Biopharmaceuticals, with products built on an immunology technology platform.

Founded in April 2006, Concert Pharmaceuticals is a clinical stage biotechnology company based in Lexington, Mass. It creates medicines through a scientific approach utilizing the naturally occurring element deuterium. Concert Pharmaceuticals Inc. has raised $110 million since its inception. The company has over 100 patent applications for new drug candidates addressing a broad range of therapeutic areas, including HIV/AIDS, and renal disease, among others. USPTO granted Concert Pharmaceutical s first patents in 2009. Some of the company s investors include Brookside Capital Partners Fund, TVM Capital, Three Arch Partners, Fidelity Investments, Skyline Ventures, Flagship Ventures, Adage Capital Management and New Leaf Venture Partners.